Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity (2025-07-31)
Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers' first choice for patients with Type 2 diabetes.